Safety, Tolerability, and Preliminary Efficacy of the Anti-Fibrotic Small Molecule PRI-724, a CBP/β-Catenin Inhibitor, in Patients with Hepatitis C Virus-related Cirrhosis: A Single-Center, Open-Label, Dose Escalation Phase 1 Trial
Kimura, Kiminori, Ikoma, Akemi, Shibakawa, Maki, Shimoda, Shinji, Harada, Kenichi, Saio, Masanao, Imamura, Jun, Osawa, Yosuke, Kimura, Masamichi, Nishikawa, Koji, Okusaka, Takuji, Morita, Satoshi, InoLangue:
english
Journal:
EBioMedicine
DOI:
10.1016/j.ebiom.2017.08.016
Date:
August, 2017
Fichier:
PDF, 805 KB
english, 2017
File converter
Plus de résultats de recherche
More benefits 
